Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Cash from Investing Activities (2018 - 2025)

Serina Therapeutics (SER) has disclosed Cash from Investing Activities for 7 consecutive years, with -$13000.0 as the latest value for Q3 2025.

  • Quarterly Cash from Investing Activities fell 333.33% to -$13000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$59000.0 through Dec 2025, down 168.18% year-over-year, with the annual reading at -$59000.0 for FY2025, 168.18% down from the prior year.
  • Cash from Investing Activities hit -$13000.0 in Q3 2025 for Serina Therapeutics, up from -$46000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $9.7 million in Q2 2023 to a low of -$10.0 million in Q1 2023.
  • Historically, Cash from Investing Activities has averaged $11909.1 across 4 years, with a median of -$13000.0 in 2025.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 10500.0% in 2021 and later crashed 333.33% in 2025.
  • Year by year, Cash from Investing Activities stood at $300000.0 in 2021, then plummeted by 123.33% to -$70000.0 in 2023, then surged by 92.86% to -$5000.0 in 2024, then tumbled by 160.0% to -$13000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for SER at -$13000.0 in Q3 2025, -$46000.0 in Q2 2025, and -$5000.0 in Q4 2024.